Thanks for the additional information.
I don't like a couple of things about Tony, another one is his pivot to running Mable and being mostly absent from TRP now days. Additionally, he doesn't come from a clinical or medical background nor any prior experience bringing a drug to market.
That said, the IP has been given no value by the market and the risk reward ratio on what is likely to be positive ph3 results is very attractive.
I hunt for the dead stocks. This is where the bags are made with very low capital.
Tissue Repair: Hidden Gem in Biotech!, page-6
-
- There are more pages in this discussion • 23 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Add TRP (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
22.5¢ |
Change
0.000(0.00%) |
Mkt cap ! $13.60M | |||
| Open | High | Low | Value | Volume |
| 0.0¢ | 0.0¢ | 0.0¢ | $0 | 0 |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 3 | 8674 | 22.5¢ |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| 25.0¢ | 11773 | 1 |
View Market Depth
| Last trade - 16.12pm 05/07/2024 (20 minute delay) ? |
| TRP (ASX) Chart |
Day chart unavailable